cubeCONSENT 3.0 - For Site INV

cubeCONSENT 3.0 - For Site INV icon

ASO Keyword Dashboard

Tracking 1 keywords for cubeCONSENT 3.0 - For Site INV in Apple App Store

Developer: (주)씨알에스큐브 Category: medical

cubeCONSENT 3.0 - For Site INV tracks 1 keyword (1 keyword ranks; full coverage across the tracked set). Key metrics: 0% top-10 coverage, opportunity 70.0, difficulty 35.7, best rank 21.

Tracked keywords

1

1  ranked •  0  not ranking yet

Top 10 coverage

0%

Best rank 21 • Latest leader 21

Avg opportunity

70.0

Top keyword: consent

Avg difficulty

35.7

Lower scores indicate easier wins

Opportunity leaders

  • consent

    Opportunity: 70.0 • Difficulty: 35.7 • Rank 21

    Competitors: 31

    51.1

Unranked opportunities

Every tracked keyword currently has some ranking data.

High competition keywords

  • consent

    Total apps: 1,191 • Major competitors: 31

    Latest rank: 21 • Difficulty: 35.7

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

Major Competitors
consent701003651

1,191 competing apps

Median installs: 1,014

Avg rating: 4.0

2121

31

major competitor apps

1 keywords
1 of 1

App Description

'cubeCONSENT 3.0® - For Site INV' is a mobile app to access the investigator portal for CRScube's eConsent solution 'cubeCONSENT 3.0®'.

App Features:
- Manage all aspects of your study's informed consent process electronically on your mobile phone.
- Create subject accounts and assign consent forms.
- View the status of assigned consent forms in real time.
- Conduct investigator signatures electronically for consent forms that have been signed by subjects.
- Upload consents forms that have been signed offline.
- Seamless integration with cubeCDMS®.

CRScube:
CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.